[ad_1]
Acting Food and Drug Administration Commissioner Janet Woodcock in a letter to Christy A. Grimm, acting inspector general at the Department of Health and Human Services, said there had been “significant interest and controversy” about approval of Aduhelm, which is made by Biogen, a Cambridge, Massachusetts, biotech company. In particular, she said, concerns continue to be raised about the agency’s communications with Biogen, including “some of which may have occurred outside the official correspondence process.”
|
Sources 2/ https://news.google.com/__i/rss/rd/articles/CBMiY2h0dHBzOi8vd3d3Lndhc2hpbmd0b25wb3N0LmNvbS9oZWFsdGgvMjAyMS8wNy8wOS9hZHVoZWxtLW5ldy1hbHpoZWltZXJzLWRydWctaGhzLWluc3BlY3Rvci1nZW5lcmFsL9IBcmh0dHBzOi8vd3d3Lndhc2hpbmd0b25wb3N0LmNvbS9oZWFsdGgvMjAyMS8wNy8wOS9hZHVoZWxtLW5ldy1hbHpoZWltZXJzLWRydWctaGhzLWluc3BlY3Rvci1nZW5lcmFsLz9vdXRwdXRUeXBlPWFtcA?oc=5 The mention sources can contact us to remove/changing this article |
[ad_2]